Inflammation & Allergy - Drug Targets (Discontinued)
Title: Editorial
Volume: 10 Issue: 1
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
S. Zaenker Kurt, Editorial, Inflammation & Allergy - Drug Targets (Discontinued) 2011; 10 (1) . https://dx.doi.org/10.2174/187152811794352060
DOI https://dx.doi.org/10.2174/187152811794352060 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Article Metrics
Related Articles
-
Use of Mouse Models to Evaluate Roles of Nuclear Receptors and their Ligands in the Pathogenesis and Treatment of Atherosclerosis
Current Drug Targets Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome
Current Molecular Medicine Erythropoietin: Cytoprotection in Vascular and Neuronal Cells
Current Drug Targets - Cardiovascular & Hematological Disorders The Role of Apoptosis in Arthritis
Current Rheumatology Reviews Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Immune Tolerance Elicited via Unique Ocular and Oral Routes
Current Molecular Medicine Targeting ADAM12 in Human Disease: Head, Body or Tail?
Current Pharmaceutical Design Review of the Fibrinolytic System: Comparison of Different Antifibrinolytics used During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery A Perspective on Water Site Prediction Methods for Structure Based Drug Design
Current Topics in Medicinal Chemistry Gene Expression Assay in the Management of Early Breast Cancer
Current Medicinal Chemistry Oxidative Stress in the Pathogenesis/Treatment of Diabetes and its Complications
Current Nutrition & Food Science Discovery of Novel Cell Proliferation-Enhancing Gene by Random siRNA Library Based Combinatorial Screening
Combinatorial Chemistry & High Throughput Screening Characterization of Regulatory T-Cells in Multiple Sclerosis Patients Treated with Interferon Beta-1a
CNS & Neurological Disorders - Drug Targets Characterization and Expression Analysis of Resistance Gene Analogues in Elite Sugarcane Genotypes
Protein & Peptide Letters Cytokine Therapy for Cancer
Current Pharmaceutical Design Design, Synthesis, and Structure-Activity Relationship Study of Peroxisome Proliferator-Activated Receptor (PPAR) δ-Selective Ligands
Current Medicinal Chemistry Cerebroprotective Functions of HO-2
Current Pharmaceutical Design Long-Chain-Fatty-Acid CoA Ligases: The Key to Fatty Acid Activation, Formation of Xenobiotic Acyl-CoA Thioesters and Lipophilic Xenobiotic Conjugates
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The IGF-I/IGF-I Receptor Pathway: Implications in the Pathophysiology of Thyroid Cancer
Current Medicinal Chemistry Overcoming Endocrine Resistance in Breast Cancer
Current Cancer Drug Targets